Exosomes Market: Rapidly Evolving Industry…… COVID-19….



The global exosomes market size is expected to reach USD 2.28 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 18.8% during the forecast period. Nanovesicles, which play a major role in intercellular communication, are anticipated to witness a significant rise in R&D, thus leading to revenue growth in the coming years.
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.
Application of these vesicles as carriers of functional content such as circulating nucleic acids, lipids, and proteins can be attributed to market growth. In addition, exosomes play an important role in immunosurveillance and tumor pathogenesis. Increasing research programs focusing on determining the role of exosomes in hepatocellular carcinoma (HCC) is estimated to drive the market.
Rising number of articles pertaining to exosomal research is encouraging R&D activities in the field. Currently, there are more than 4400 articles published about exosomes, with approximately 25% of these published in 2016 alone. In addition to the exponential rise in article publication, number of companies engaged in the research is also increasing.
These companies are taking advantage of the natural propensity of exosomes for the transmission of macromolecule payloads between cells. Application of these molecules in research activities related to therapeutics and diagnostics is projected to result in exponential growth in the coming years.
Moreover, increase in funding for R&D in this field is poised to positively influence industrial growth. Rise in funding capacity by public and private institutions is indicative of the importance of exRNA molecules across the community engaged in translational research pertaining to diagnostics and therapeutic product development.
To Request Sample Copy of this report, click the link:
Further key findings from the report suggest:
·         By workflow, downstream analysis will account for a little over half the market revenue in 2030, due to rising advancements in methods and instruments
·         Ultracentrifugation represented the leading share in the isolation methods segment owing to higher adoption of technology as compared to other methods of isolation. Immunocapture on beads is anticipated to witness the fastest growth over the forecast period due to advancements in lab-on-a-chip techniques
·         In 2016, cancer was the leading application segment with a valuation of USD 1.15 million. Increasing penetration of companies in oncology-based research on biomarker identification is contributing to the growth of the segment
·         North America commanded the dominant share in terms of market revenue due to presence of a large number of academic and private organizations engaged in the launch of novel technologies
·         Major participants operating in this sector include Takara Bio Company; Illumina, Inc.; Thermo Fisher Scientific, Inc.; Fujifilm; and Qiagen. Strategies adopted by these participants include patent filing, inauguration of certified production facility, and launch of novel instruments.
The global exosomes market size was estimated at USD 3.00 million in 2016. However, exponential growth in revenue is anticipated over the coming decade due to granular and bottom-up efforts made by researchers in the field. Rising number of research grants and projects by various research organizations will also contribute toward market growth.
Projects are being undertaken to develop methods that enable efficient isolation and characterization of exosomal vesicles. Participation of exosomes in different functions and availability of a wide variety of pathways are expected to fuel research in field, thereby leading to revenue generation. Rise in research funding is also expected to boost the market in the coming years. For instance, in August 2013, the U.S. National Institutes of Health announced the funding of USD 17 million for 24 research projects focusing on extracellular RNA.
Small companies flooding the marketplace and development of novel platforms and advanced technologies will also drive market growth over the forecast period. New platforms enable detection of low abundant membrane proteins and this detection can be carried out even in the background of complex plasma proteins.
In addition to this, the role of exosomes in providing insights for the diagnosis of pathological conditions is anticipated to increase its adoption in the research arena. Exosomes belong to the family of nanovesicles, which serve many functions in the diagnosis and therapy of multiple diseases.
Browse Press Release of this report:
Grand View Research has segmented the global exosomes market on the basis of workflow, biomolecule type, application:
Exosomes Workflow Outlook (Revenue, USD Million, 2014 - 2030)
·         Isolation Methods
o    Ultracentrifugation
o    Immunocapture on beads
o    Precipitation
o    Filtration
·         Downstream Analysis
o    Cell Surface Marker Analysis using Flow Cytometry
o    Protein analysis using Blotting & ELISA
o    RNA analysis with NGS & PCR
o    Proteomic analysis using Mass Spectrometry
o    Others
Exosomes Biomolecule Type Outlook (Revenue, USD Million, 2014 - 2030)
·         Non-coding RNAs
·         mRNA
·         Proteins /peptides
·         DNA fragments
·         Lipids
Exosomes Application Outlook (Revenue, USD Million, 2014 - 2030)
·         Cancer
·         Neurodegenerative diseases
·         Cardiovascular diseases
·         Infectious diseases
·         Others
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..